| Term 
 
        | Hypertension most common CV disease 24% total USA population   increased incidence of Renal Failure, Coronary Disease, CF & Stroke. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Diagnosis   repeated BP measurement 3 times, normal: 120/90mm Hg often asymptomatic     |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Essential Hypertension unknown cause through multi-factors such as: Hyperlipidemia Diabetes Genetic, family hxy Diet Stress   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 5-10% Identifiable Causes: Renal Artery Constriction Coarctation of Aorta Phaeochromocytoma (tumor of adrenal glands) Cushing's Disease (hypercortisolism) Primary Aldosteronism (elevated aldosterone) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Treatments 4 sites of regulations Arterioles: resistance Venules: capacitance Heart: pump output Renal angiotensin system: volume (triggered by low BP) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Major Drug Groups: Diuretics: pee more Sympathoplegics: block SNS Vasodilators Angiotensin Antagonists |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Diuretics   2 main actions: ↓ Blood volume affect smooth muscle tone     |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 1, Tiazides: hydrochlorothiazide (mild/mod HT)   block Na/Cl symporter, Ca reabsorption distal convoluted tubule orally active, maybe used as mono-therapy Toxicity: K depletion/hypokalemia |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2, Loop Diuretics: furosemide( severe HT)   Block Na/K/2Cl symporter, Ca excretion thick ascending loop and convoluted loop Oral & IV Toxicity: K depletion/Hypokalemia may cause arthythmias |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sympathoplegics Targets: Centrally acting agents Ganglion Blockers: nicotinic antagonist Postganglionic sympathetic neuron blocker Adrenoceptor blockers: found in heart and blood vessel.   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 1, Centrally Acting Agents: α2-selective agonists when α2 gets stimulated, they reduce the amount of NE release into CNS. 
 eg: Clonidine (mild/mod HTN).It block SNS.  Minimal toxicity. 
 Methyldopa
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2, Ganglion Blockers:  Nicotinic cholinoreceptor antagonists eg: Trimethaphan (severe HTN) blocks nACh R in autonomic ganglia Toxicity: intolerable, used rarely due to CNS, PNS effect, orthostatic htn, constipation, blurred vision   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 3, Postganglionic SNS blockers Reserpine, Guanethidine rarely usedReserpine blocks uptake
 Guanethidine prevents neurotransmitter release. Toxicity: Intolerable, depression, sexual dysfxn, ortho htn
 
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 4, Adrenoceptor Blockers:  α1 and β1 receptor antagonists eg: Prazosin: block α1 receptor
 Propanolol: block β1 receptor B blocker works more on the blood vessel whereas a blocker works on the heart. 
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Vasodilators: dilate arterioles in diff mechanisms: 1, release of nitric oxide   2, Open K channel, hypopolarization   3, Block L-type Ca channels, reduce the tone |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Vasodilators     They all reduce excitability therefore reduce the tone |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 1, Nitrovasodilators: eg: Hydralazine, Nitroprusside It activate soluble Guanylate Cyclase, it negatively regulates the Ca channel. It shuts Ca channel, less Ca gets in, so less smooth muscle tone. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2, K channel Agonist eg: Minoxidil sulfate, Diazoxide severe HTN, for HTN emergency!!    it interfere not only with the blood vessel but also the heart. 
 
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 3, Ca channel Blockers 3 types of Ca channels L-, T-, and N-type L-type opens long, important in regulating contractility of blood vessel. Main target of HTN drugs T-type is transient N-type is presynaptic |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 3 main classes of blockers Vasoselective: Dihydropyridines (Nifedipine)   Cardiac & Vascular Acting:  Phenylalkylamines (Verapamil) Benzothiazines ( Diltiazem  ) 
 
 
 
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        |   Due to difference in frequence of Ca channel activity They are selective in different tissue   Each drug has a distinct allosteric binding site
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        |     Ca channel blockers Verapamil, Diltiazem, Nifedipine voltage & frequency dependent block   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        |   Nifedipine Adverse Effects:   17%-20% pts experience:   Hypotension, H/A, Peripheral edema |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Angiotensin Antagonists 1, ACE inhibitors: Captopril prevents the conversion from angiotensin 1 to angiotensin 2 Angiotensin 2 is responsible for vasoconstriction & aldosterone secretion
 2, Angiotensin Receptor inhibitor (AT1-type): Losartan   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        |     Captopril cause irritable cough, not good for pregnant women. Therefore they develope Losartan. Losartan has less toxicity |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Captopril and Losartan are for Mild-Mod HTN for mono-therapy   ACE inhibitor also prevent breakdown of Bradykinin |  | Definition 
 | 
        |  | 
        
        | Term 
 
        |  maximize efficacy and minimize toxicity, we combine drug from different group eg: diuretic+sympathoplegic+vasodilator    For emergency or malinant htn, pt are hospitalized and treated with parenteral vasodilator, B-blocker, and loop diuretic |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Multiply possibilities of untreated HTN: Heart: hypertrophy, MI, HF Brain: stroke Kidney: renal failure, chronic kidney disease Vasculature: peripheral vascular disease Eye: retinopathy |  | Definition 
 | 
        |  |